Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
FTH holding history
Faeth Therapeutics, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FTH overviewAll 13F holders of FTHFull Q2 2026 holdings
- Shares (Q2 2026)
- 35,386
- Value
- $884.6K
- % of portfolio
- 0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 35,386 | $884.6K | 0.1% | +29,035+457.2% | Added | Holders |
| Q1 2026 | 6,351 | $200.2K | <0.1% | −15,000−70.3% | Reduced | Holders |
| Q4 2025 | 21,351 | $227.8K | <0.1% | −1,146−5.1% | Reduced | Holders |
| Q3 2025 | 22,497 | $212.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 22,497 | $193.0K | 0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q1 2025 | 449,963 | $177.3K | 0.1% | −200,000−30.8% | Reduced | Holders |
| Q4 2024 | 649,963 | $318.5K | 0.1% | −370.0% | Reduced | Holders |
| Q3 2024 | 650,000 | $388.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 650,000 | $403.1K | 0.1% | +650,000 | New | Holders |